0001415889-15-000169.txt : 20150116 0001415889-15-000169.hdr.sgml : 20150116 20150116175100 ACCESSION NUMBER: 0001415889-15-000169 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150114 FILED AS OF DATE: 20150116 DATE AS OF CHANGE: 20150116 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACADIA PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001070494 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 061376651 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11085 TORREYANA ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-558-2871 MAIL ADDRESS: STREET 1: 11085 TORREYANA ROAD STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hacksell Uli CENTRAL INDEX KEY: 0001291962 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50768 FILM NUMBER: 15533514 MAIL ADDRESS: STREET 1: 3911 SORRENTO VALLEY BOULEVARD CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 form4-01162015_020151.xml X0306 4 2015-01-14 0001070494 ACADIA PHARMACEUTICALS INC ACAD 0001291962 Hacksell Uli 11085 TORREYANA ROAD #100 SAN DIEGO CA 92121 true true false false CEO Common Stock 2015-01-14 4 M 0 30000 2 A 30000 D Common Stock 2015-01-14 5 G 0 30000 0 D 0 D Common Stock 2015-01-14 5 G 0 30000 0 A 145549 I By Family Trust Common Stock 2015-01-14 4 S 0 30000 33.981 D 115549 I By Family Trust Stock Option (right to buy) 2 2015-01-14 4 M 0 30000 0 D 2018-10-19 Common Stock 30000 0 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in March 2014. The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $33.68 to $34.33 per share, inclusive. The reporting person undertakes to provide ACADIA Pharmaceuticals Inc., any security holder of ACADIA Pharmaceuticals Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the foregoing range. 50% of the shares subject to the stock option vested and became exercisable on October 20, 2010. The remaining shares vested in equal monthly installments over the following 2 years. /s/ Glenn F. Baity, Attorney-in-Fact 2015-01-16